Total and out-of-pocket costs of different primary management strategies in ovarian cancer.

ABSTRACT:

Background

Communicating healthcare costs to patients is an important component of delivering high-quality value-based care, yet cost data are lacking. This is especially relevant for ovarian cancer, where no clinical consensus on optimal first-line treatment exists.

Objective

The objective of this study was to generate cost estimates of different primary management strategies in ovarian cancer.

Study design

All women who underwent treatment for ovarian cancer from 2006-2015 were identified from the MarketScan database (n=12,761) in this observational cohort study. Total and out-of-pocket costs were calculated with the use of all claims within 8 months from initial treatment and normalized to 2017 US dollars. The generalized linear model method was used to assess cost

SUBMITTER: Suidan RS 

PROVIDER: S-EPMC7392324 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature